Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Target Price at $33.22

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven research firms that are currently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $33.22.

Several equities analysts recently commented on XRAY shares. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating for the company in a research report on Monday, July 22nd. Evercore ISI dropped their target price on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an "outperform" rating for the company in a research report on Tuesday, July 9th. Stifel Nicolaus dropped their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a research report on Thursday, July 18th. Needham & Company LLC restated a "buy" rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $36.00 price objective on shares of DENTSPLY SIRONA in a research report on Friday, September 20th.

DENTSPLY SIRONA Trading Down 4.3 %

DENTSPLY SIRONA stock traded down $1.12 during mid-day trading on Wednesday, hitting $25.00. 2,944,689 shares of the stock were exchanged, compared to its average volume of 3,043,831. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $5.19 billion, a price-to-earnings ratio of -59.36, a PEG ratio of 1.30 and a beta of 1.00. The firm's fifty day simple moving average is $25.55 and its two-hundred day simple moving average is $27.47. DENTSPLY SIRONA has a 12 month low of $23.58 and a 12 month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same quarter in the previous year, the company posted $0.51 EPS. The business's quarterly revenue was down 4.3% on a year-over-year basis. Analysts forecast that DENTSPLY SIRONA will post 1.99 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 2.56%. The ex-dividend date is Friday, September 27th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -145.45%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. First Eagle Investment Management LLC lifted its stake in shares of DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier's stock valued at $325,571,000 after purchasing an additional 3,283,965 shares during the last quarter. Generation Investment Management LLP raised its stake in DENTSPLY SIRONA by 43.4% during the fourth quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier's stock worth $234,830,000 after acquiring an additional 1,998,012 shares in the last quarter. Wellington Management Group LLP boosted its position in DENTSPLY SIRONA by 21.1% in the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier's stock valued at $289,640,000 after buying an additional 1,419,503 shares in the last quarter. SG Americas Securities LLC lifted its position in DENTSPLY SIRONA by 2,959.1% during the 1st quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier's stock worth $45,584,000 after buying an additional 1,328,525 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of DENTSPLY SIRONA by 42.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier's stock valued at $110,118,000 after purchasing an additional 1,308,411 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.